Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese Patients
Background: Hepatocellular carcinoma (HCC) is among the leading causes of cancer deaths in China. Considering its poor prognosis when diagnosed late, Chinese guidelines recommend biannual screening for HCC with abdominal ultrasound and serum α-fetoprotein (AFP) test for high-risk populations. Object...
Guardado en:
Autores principales: | Kerui Xu, Shinobu Watanabe-Galloway, Fedja A. Rochling, Jianjun Zhang, Paraskevi A. Farazi, Hongyan Peng, Hongmei Wang, Jiangtao Luo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Ubiquity Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b22dde2c44774b25a58ec021e3d3ab02 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
por: Xuemei Yang, et al.
Publicado: (2021) -
NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021) -
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020) -
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021) -
Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021)